Lidoproct

Lidocaine, the active ingredient in Lidoproct, is a local anesthetic presented as a rectal formulation for topical analgesia. It provides temporary numbing of the anorectal region and is used to alleviate pain associated with haemorrhoids, anal fissures and other proctologic procedures.

GNH USA supplies Lidoproct as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to EU and other markets. Customers benefit from reliable logistics and on‑time delivery across multiple continents.

Lidoproct (lidocaine) is applied rectally to provide local anesthesia for anorectal conditions.

- Haemorrhoidal disease: reduces pain and discomfort during flare‑ups. - Anal fissure: provides temporary numbness to facilitate bowel movements and healing. - Post‑operative anorectal surgery: alleviates procedural pain and spasm. - Proctalgia fugax: diminishes episodic rectal pain attacks.

Lidoproct may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Burning or stinging at the application site. - Local irritation or redness. - Transient numbness extending beyond the intended area. - Mild dizziness or headache.

Serious or Rare Side Effects: - Allergic reactions such as rash, swelling, or anaphylaxis. - Seizures or convulsions due to systemic toxicity. - Cardiac arrhythmias, including bradycardia or ventricular disturbances.

Before using Lidoproct, consider the following safety measures.

- Allergy assessment: confirm no known hypersensitivity to lidocaine or amide‑type anesthetics. - Dosage limitation: use only the amount prescribed to avoid systemic toxicity. - Concurrent anesthetics: avoid using other topical or injectable local anesthetics simultaneously. - Medical conditions: exercise caution in patients with hepatic impairment or cardiac conduction disorders. - Pregnancy and lactation: discuss potential risks with a healthcare professional before use. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Lidoproct can interact with other medications; awareness of potential interactions helps prevent adverse effects.

Major Interactions (Avoid): - Other local anesthetics (e.g., bupivacaine, benzocaine): risk of cumulative systemic toxicity. - Class I antiarrhythmic agents (e.g., quinidine, procainamide): may enhance cardiac conduction disturbances. - Strong CYP1A2 or CYP3A4 inhibitors (e.g., cimetidine, erythromycin): increase lidocaine plasma levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers (e.g., propranolol): may potentiate bradycardia. - Central nervous system depressants (e.g., benzodiazepines, alcohol): can augment sedation and dizziness. - Diuretics (e.g., furosemide): may lower plasma protein binding, modestly raising free lidocaine concentration.